Clinical Trial Update: Ciclosporin Followed by Low-dose IL-2 in Patients With Recently Diagnosed Type 1 Diabetes [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating ciclosporin followed by low-dose IL-2 in individuals recently diagnosed with Type 1 diabetes; the study is currently recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Aldesleukin (interleukin-2)
• CYCLOSPORINE (cyclosporine)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Type 1 Diabetes | Phase 2 | Status: RECRUITING